In the present study, we highlight the multifaceted role of PIVKA-II, a vitamin-K-dependent abnormal prothrombin, classically associated with HCC diagnosis, now emerging as a relevant biomarker in PDAC. The gene discussed is F2; the disease is hepatocellular carcinoma.